National Institutes of Health (NIH)-supported investigators have developed a blood test to find pancreatic ductal ...
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...
As more consumers order up lab tests and genetic screenings, experts say it could impact insurance, loans, and employment decisions.
A new finger prick test claims to detect Alzheimer’s with 91% accuracy using p-tau217 biomarkers. Learn how this accessible ...
DiaCardia, a novel artificial intelligence model that can accurately identify individuals with prediabetes using either ...
In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, accessible and inexpensive than other existing tests. When you purchase through ...
New research suggests that immunotherapy given before and after surgery could help patients with diffuse pleural mesothelioma, one of the most challenging cancers to treat. A phase II clinical trial ...
A pioneering AI-enabled multi-cancer blood test, developed with the NHS in England, will be among the headline innovations ...
Scientists from the University of Exeter has developed a precise method to interpret ankle blood pressure readings—an innovation that could transform care for people unable to have their arm blood ...
This article is part of "Build IT: Connectivity," a series about tech powering better business. Viome is aiming to transform disease detection, starting with the gut. The Washington-based biotech ...
The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results